Similar articles for PMID: 22688778

Year	Number of Results
2007	2
2008	3
2009	8
2010	9
2011	14
2012	17
2013	21
2014	32
2015	41
2016	25
2017	29
2018	13
2019	8
2020	5
2021	11
2022	5
2024	0

1

Comparative effectiveness of anti-growth factor therapies for diabetic macular edema: summary of primary findings and conclusions.

O'Malley PG. O'Malley PG. Arch Intern Med. 2012 Jul 9;172(13):1014-5. doi: 10.1001/archinternmed.2012.2335. Arch Intern Med. 2012. PMID: 22688778 Review. No abstract available.

2

Comparative effectiveness of anti-VEGF agents for diabetic macular edema.

Ollendorf DA, Colby JA, Pearson SD. Ollendorf DA, et al. Int J Technol Assess Health Care. 2013 Oct;29(4):392-401. doi: 10.1017/S0266462313000500. Int J Technol Assess Health Care. 2013. PMID: 24290332 Review.

3

[Anti-VEGF therapy to treat diabetic macular edema].

Takamura Y. Takamura Y. Nippon Ganka Gakkai Zasshi. 2014 Sep;118(9):747-9. Nippon Ganka Gakkai Zasshi. 2014. PMID: 25318182 Japanese. No abstract available.

4

Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema: Extrapolation of Data to Clinical Practice.

Heier JS, Bressler NM, Avery RL, Bakri SJ, Boyer DS, Brown DM, Dugel PU, Freund KB, Glassman AR, Kim JE, Martin DF, Pollack JS, Regillo CD, Rosenfeld PJ, Schachat AP, Wells JA 3rd; American Society of Retina Specialists Anti-VEGF for Diabetic Macular Edema Comparative Effectiveness Panel. Heier JS, et al. JAMA Ophthalmol. 2016 Jan;134(1):95-9. doi: 10.1001/jamaophthalmol.2015.4110. JAMA Ophthalmol. 2016. PMID: 26512939

5

Anti-VEGF therapeutic approaches for diabetic macular edema.

Khurana RN, Do DV, Nguyen QD. Khurana RN, et al. Int Ophthalmol Clin. 2009 Spring;49(2):109-19. doi: 10.1097/IIO.0b013e31819fd8b5. Int Ophthalmol Clin. 2009. PMID: 19349791 No abstract available.

6

Comparative Effectiveness Trial for Diabetic Macular Edema: Three Comparisons for the Price of 1 Study From the Diabetic Retinopathy Clinical Research Network.

Jampol LM, Glassman AR, Bressler NM. Jampol LM, et al. JAMA Ophthalmol. 2015 Sep;133(9):983-4. doi: 10.1001/jamaophthalmol.2015.1880. JAMA Ophthalmol. 2015. PMID: 26087135 Free PMC article. No abstract available.

7

Diabetic macular edema.

Lang GE. Lang GE. Ophthalmologica. 2012;227 Suppl 1:21-9. doi: 10.1159/000337156. Epub 2012 Apr 24. Ophthalmologica. 2012. PMID: 22517122 Review.

8

Higher priced drugs are not cost effective for diabetic macular edema, US study finds.

McCarthy M. McCarthy M. BMJ. 2016 Jun 9;353:i3253. doi: 10.1136/bmj.i3253. BMJ. 2016. PMID: 27283845 No abstract available.

9

Biological, preclinical and clinical characteristics of inhibitors of vascular endothelial growth factors.

Chong V. Chong V. Ophthalmologica. 2012;227 Suppl 1:2-10. doi: 10.1159/000337152. Epub 2012 Apr 24. Ophthalmologica. 2012. PMID: 22517120 Review.

10

Evidence for anti-VEGF treatment of diabetic macular edema.

Bandello F, Berchicci L, La Spina C, Battaglia Parodi M, Iacono P. Bandello F, et al. Ophthalmic Res. 2012;48 Suppl 1:16-20. doi: 10.1159/000339843. Epub 2012 Aug 21. Ophthalmic Res. 2012. PMID: 22907145 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

222 results

Results by year